Ana Laín
Impact in
- Infectious Diseases top 10%
- Antifungal resistance and susceptibility
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Biotechnology top 10%
- Enzyme Production and Characterization
Papers in
-
- Porphyrin Metabolism and Disorders 7
- Metabolomics and Mass Spectrometry Studies 6
- Protein Structure and Dynamics 3
-
- Antifungal resistance and susceptibility 5
- COVID-19 Clinical Research Studies 1
- Co-authors
- Óscar Millet (14 shared papers)David Castaño (4 shared papers)Blanca Lopez Mendez (2 shared papers)Xavier Tadeo (2 shared papers)José Pontón (5 shared papers)Maria Dolores Moragues (5 shared papers)José María Mato (6 shared papers)Gabriel Ortega (2 shared papers)
In The Last Decade
Ana Laín
23 papers receiving 832 citations
Peers
Comparison fields: 5 of 83
- Infectious Diseases 242
- Biotechnology 62
- Molecular Biology 496
- Clinical Biochemistry 17
- Neurology 25
Countries citing papers authored by Ana Laín
This map shows the geographic impact of Ana Laín's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Laín with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Laín more than expected).
Fields of papers citing papers by Ana Laín
This network shows the impact of papers produced by Ana Laín. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Laín. The network helps show where Ana Laín may publish in the future.
Co-authors
The 25 scholars most cited alongside Ana Laín, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 181 | |
| 2 | 2009 | 153 | |
| 3 | 2011 | 64 | |
| 4 | 2018 | 44 | |
| 5 | 2021 | 44 | |
| 6 | 2007 | 36 | |
| 7 | 2019 | 34 | |
| 8 | 2021 | 34 | |
| 9 | 2007 | 33 | |
| 10 | 2013 | 31 | |
| 11 | 2020 | 31 | |
| 12 | 2008 | 30 | |
| 13 | 2008 | 27 | |
| 14 | 2014 | 19 | |
| 15 | 2011 | 15 | |
| 16 | 2019 | 15 | |
| 17 | 2008 | 14 | |
| 18 | 2022 | 12 | |
| 19 | 2024 | 9 | |
| 20 | 2005 | 8 |
About Ana Laín
Ana Laín is a scholar working on Molecular Biology, Infectious Diseases, Clinical Biochemistry, Neurology and Epidemiology, having authored 23 papers that have together received 850 indexed citations. Recurring topics across this work include Porphyrin Metabolism and Disorders (7 papers), Metabolomics and Mass Spectrometry Studies (6 papers), Antifungal resistance and susceptibility (5 papers), Protein Structure and Dynamics (3 papers), Metabolism and Genetic Disorders (2 papers), COVID-19 Clinical Research Studies (1 paper), Fungal Infections and Studies (1 paper) and Enzyme Structure and Function (1 paper). The work is most often cited by research in Infectious Diseases (242 citations), Biotechnology (62 citations), Molecular Biology (496 citations), Clinical Biochemistry (17 citations) and Neurology (25 citations). Ana Laín has collaborated with scholars based in Spain, Germany and France. Frequent co-authors include Óscar Millet, David Castaño, Blanca Lopez Mendez, Xavier Tadeo, José Pontón, Maria Dolores Moragues, José María Mato, Gabriel Ortega, Ganeko Bernardo‐Seisdedos and Chiara Bruzzone. Their work appears in journals such as Cardiovascular Diabetology, Biochemistry, NMR in Biomedicine, Science Translational Medicine and ACS Central Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.